-
Novartis Contends Beovu Safety Should Not Be In Dispute As Current Drug Label Provides Sufficient Warnings
At Issue Is Dangerous Form Of Eye Inflammation, Occlusive Retinal Vasculitis, Which Can Lead To Vision Loss Or Blindness (Posted by Tom Lamb at DrugInjuryWatch.com) On March 2, 2020 Novartis stated that…
-
Beovu Side Effects Include Retinal Vasculitis, Eye Inflammation: Safety Issues For Macular Degeneration Drug
News Reports: There Have Been 11 Cases Of Beovu-Associated Occlusive Retinal Vasculitis, Which Can Lead To Blindness (Posted by Tom Lamb at DrugInjuryWatch.com) Several late February 2020 news articles report that the…
-
Belviq Recall: FDA Warning Cancer Risks Of Diet Drug Belviq Outweigh Benefits — February 2020
Excess Cases Of Pancreatic Cancer, Colon Cancer, Rectal Cancer, And Lung Cancer Observed In Belviq Safety Clinical Trial (Posted by Tom Lamb at DrugInjuryWatch.com) On February 13, 2020 the FDA requested Eisai…
-
Hypophosphatemia As A Side Effect Of Injectafer vs. Monoferric Treatments: Comparisons From Two Clinical Trials
New JAMA Medical Journal Article Reports A Significant Higher Hypophosphatemia Incidence Rate With Injectafer Compared To Monoferric (Posted by Tom Lamb at DrugInjuryWatch.com) In this earlier article, “Injectafer-Induced Hypophosphatemia Can Be A…
-
Injectafer-Induced Hypophosphatemia Can Be A Serious Side Effect Of This Iron Deficiency Anemia Drug
Hypophosphatemia Is An Injectafer Side Effect With Possible Medical Complications Leading To Hospitalization Or Death (Posted by Tom Lamb at DrugInjuryWatch.com) Injectafer (ferric carboxymaltose) is an iron replacement injection approved by the…
